MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer

Not yet recruiting
Conditions
Ovarian Cancer
First Posted Date
2025-04-13
Last Posted Date
2025-04-13
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT06925126

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Phase 2
Not yet recruiting
Conditions
Biliary Tract Cancer (BTC)
Interventions
First Posted Date
2025-04-09
Last Posted Date
2025-04-09
Lead Sponsor
Fudan University
Target Recruit Count
74
Registration Number
NCT06919848
Locations
🇨🇳

Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 2
Not yet recruiting
Conditions
Gastric Adenocarcinoma
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
Peritoneal Metastasis
Interventions
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
Fudan University
Target Recruit Count
30
Registration Number
NCT06914687

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Phase 2
Recruiting
Conditions
Pancreatic Neoplasms
Interventions
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
Fudan University
Target Recruit Count
30
Registration Number
NCT06914674
Locations
🇨🇳

Shanghai Cancer Center, Shanghai, China

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Phase 2
Recruiting
Conditions
Endometrial Cancer
Interventions
Drug: TQB2450 injection + oral progestin
First Posted Date
2025-04-06
Last Posted Date
2025-04-30
Lead Sponsor
Fudan University
Target Recruit Count
10
Registration Number
NCT06914297
Locations
🇨🇳

Tenth People's Hospital of Tongji University, Shanghai, Shanghai, China

Neoadjuvant SNF Precision Therapy Phase III

Phase 3
Not yet recruiting
Conditions
Neoadjuvant Therapy
Interventions
Drug: Chemotherapy (wP-EC)
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
Fudan University
Target Recruit Count
404
Registration Number
NCT06913777
Locations
🇨🇳

Fudan University Shanghai Cancer Center,, Shanghai, Shanghai, China

Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer
Cytology
Sentinel Lymph Node
Frozen Section
First Posted Date
2025-04-04
Last Posted Date
2025-04-04
Lead Sponsor
Fudan University
Target Recruit Count
709
Registration Number
NCT06911528
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases

Recruiting
Conditions
Colorectal Cancer
Peritoneal Metastases
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
Fudan University
Target Recruit Count
50
Registration Number
NCT06903325
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Lung Atelectasis Improvement Through Positive End Expiratory Pressure During Anesthetic Induction

Not Applicable
Not yet recruiting
Conditions
Lung Injury, Acute
First Posted Date
2025-03-28
Last Posted Date
2025-03-28
Lead Sponsor
Fudan University
Target Recruit Count
120
Registration Number
NCT06900426
Locations
🇨🇳

Fudan University Shanghai Cancer Centre, Shanghai, Shanghai, China

An Observational Study for Gastric Cancer in Asymptomatic Carriers of High Risk Helicobacter Pylori

Not yet recruiting
Conditions
Gastric (Stomach) Cancer
Helicobacter Infection
First Posted Date
2025-03-26
Last Posted Date
2025-03-26
Lead Sponsor
Fudan University
Target Recruit Count
6000
Registration Number
NCT06896370
© Copyright 2025. All Rights Reserved by MedPath